In this article, we will look at the 10 Best Rising Penny Stocks to Buy According to Analysts.
Small-Cap Performance in Q1 2025
The start of 2025 was characterized by a series of challenges for the US equities across the board. Tariffs, inflationary concerns, the risk of recession, and loss of consumer confidence, all led to the small-cap Russell 2000 Index falling 9.5% and the large-cap Russell 1000 Index falling 4.5%. On April 1, Royce Investment released its fiscal first quarter outlook for small-cap stocks. Francis Gannon, who is the Co-Chief Investment Officer, and Managing Director, noted that while the large-cap outperformed the small-caps, however, this performance was not concentrated among the Magnificent Seven, which has dominated the market previously. This is evident from the fact that the Russell Top 50 Index fell 7.6%, whereas the NASDAQ Composite was down more than 10.3%.
Gannon highlighted that while the small-cap stocks underperformed the large caps, however, the divergence from the Mag Seven is a positive trend for the small-cap stocks. He noted that historically speaking the broadening of the market away from the top few stocks has meant good things for the small caps in the long term.
Moreover, while dissecting the performance of small-cap equities during the downturn, Gannon noted that the Russell 2000 Value Index held better as compared to the Russell 2000 Growth Index. The small-cap value stocks have outperformed the growth counterparts over 1 and 5-year comparisons. However, when looked up from a 10-year standpoint the performance for both categories remains the same. Gannon further pointed out that during the first quarter of 2025, the biggest detractors of the Index were Information Technology, Industrials, Health Care, and Consumer Discretionary, while Utilities was the only positive contributor.
Lasty, Gannon shared his experience of being a small-cap investment strategist for over 50 years. He highlighted it is still too early to tell if the first quarter drop for small-cap stocks was only short-term or indicates a long-term period of falling, however, he noted that corrections are common for the small-cap investors. Gannon advised investors to learn to be greedy when others are fearful and vice versa if they are interested in small caps. Moreover, looking at the stocks from a valuation standpoint, small caps remain largely undervalued as compared to large caps and Gannon advised the key to tackling periods of uncertainty is to remain invested.
With that let’s take a look at the 10 best rising penny stocks to buy according to analysts.
Stocks
Our Methodology
To compile the list of the 10 best-rising penny stocks to buy according to analysts, we used the Finviz stock screener and CNN. Using the screener, we aggregated the list of penny stocks (trading between $1 and $5) with more than 30% share price appreciation over the past month, and more than 30% average upside potential. Lastly, we sorted the list by market capitalization and ranked the stocks in ascending order of the number of hedge funds sourced from Insider Monkey’s Q4 2024 database. Please note that the data was collected on April 17, 2025.
Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter’s strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (see more details here).
10 Best Rising Penny Stocks to Buy According to Analysts
10. TMC the metals company Inc. (NASDAQ:TMC)
Price: $2.87
1-Month Performance: 58.56%
Analyst Upside Potential: 46.34%
Number of Hedge Fund Holders: 5
TMC the metals company Inc. (NASDAQ:TMC) is a deep-sea mineral exploration company that focuses on collecting and processing polymetallic nodules, which are rock-like deposits in nickel, copper, cobalt, and manganese. The company then processes these nodules to extract metals that are used for high-growth industries including electric vehicle batteries and renewable storage.
On March 31, Alliance Global Partners raised the firm’s price target on the company from $3.75 to $4.50, while keeping a Buy rating on the stock. The upgrade was based on the company’s 2024 results and a significant change in permitting strategy. TMC the metals company Inc. (NASDAQ:TMC) is shifting to a permitting path under the U.S. Deep Seabed Hard Mineral Resources Act (DSHMRA). Previously, the company was relying on ISA’s yet-to-be-adopted mining code, which led to delays. Although the company reported a net loss of $81.9 million for the year and liquidity of about $43 million. However, analysts expect TMC, the metals company Inc. (NASDAQ:TMC) to rise making it one of the best-rising penny stocks to buy according to analysts.
9. Theratechnologies Inc. (NASDAQ:THTX)
Price: $2.66
1-Month Performance: 65.22%
Analyst Upside Potential: 46.62%
Number of Hedge Fund Holders: 4
Theratechnologies Inc. (NASDAQ:THTX) is a pharmaceutical company based in Canada. It focuses on developing commercialized treatments for HIV, Oncology, and Nonalcoholic Steatohepatitis. The company currently markets two main prescription products for HIV in the United States including the EGRIFTA SV and Trogarzo.
On April 11, Theratechnologies Inc. (NASDAQ:THTX) was upgraded to Buy from a Hold by The JonesResearch, with a price target of $3. Future Pak has made an offer to acquire the company, which the boards of directors are reviewing. Management has formed a special committee to evaluate the potential sale, however, analysts believe that it is unlikely that this offer would convert into a transaction.
On the other hand, Theratechnologies Inc. (NASDAQ:THTX) has been doing well financially. It grew its revenue by 17% year-over-year to reach $19 million during the first quarter of 2025. The growth was driven by EGRIFTA SV sales which improved 44.8% during the same time. The stock has improved more than 65% over the past month, making it one of the best-rising penny stocks to buy according to analysts.
8. Satixfy Communications Ltd. (NYSEAMERICAN:SATX)
Price: $1.99
1-Month Performance: 46.32%
Analyst Upside Potential: 50.75%
Number of Hedge Fund Holders: 2
Satixfy Communications Ltd. (NYSEAMERICAN:SATX) is a technology company based in Israel that engages in developing satellite communication technology. Its key systems include satellite payloads, chipsets, modems and terminals, and network management systems.
The company released its full-year results demonstrating growth in 2024. Its revenue reached $20.6 million, representing a 92% increase year-over-year. This came in above management’s guidance of $17-19 million for the year and was driven by the Development Services and Pre-Production segment which made $13.1 million, representing a 59% increase, and product sales, which grew 204% year-over-year.
In addition to this, Satixfy Communications Ltd. (NYSEAMERICAN:SATX) secured significant contracts in 2024 including the Telesat Contract, MDA Space Collaboration, and Prime2 Space-Grade Digital Beam Former Chips. It is one of the best-rising penny stocks to buy according to analysts.
7. Integra Resources Corp. (NYSEAMERICAN:ITRG)
Price: $1.71
1-Month Performance: 31.54%
Analyst Upside Potential: 64.62%
Number of Hedge Fund Holders: 5
Integra Resources Corp. (NYSEAMERICAN:ITRG) is a precious metal mining company engaged in the production of gold and silver. The company’s principal operating asset is the Florida Canyon Mine in Nevada. Moreover, it is also developing the DeLamar Project in southwestern Idaho and the Nevada North Project in western Nevada.
On April 4th, Raymond James analyst Brian MacArthur raised the price target for the stock from C$3.25 to C$3.75 and maintained an Outperform rating. One of the reasons behind the upgrade is the updated commodity price forecast by the firm. Raymond James anticipates an increase in gold and silver prices in the near and long term, which considering the higher reserve and resource pricing of Integra Resources Corp. (NYSEAMERICAN:ITRG) is expected to benefit the company. Moreover, the company reported record gold production in fiscal 2024, which reached 72,229 ounces, exceeding the guidance. As a result, the net income for the fourth quarter alone came in at $9.5 million. It is one of the best-rising penny stocks to buy according to analysts.
6. HF Foods Group Inc. (NASDAQ:HFFG)
Price: $3.99
1-Month Performance: 63.52%
Analyst Upside Potential: 75.44%
Number of Hedge Fund Holders: 2
HF Foods Group Inc. (NASDAQ:HFFG) is a Chinese marketer and distributor of fresh, frozen, and dry food. It primarily serves Asian and Chinese restaurants as well as some customers across the United States.
The company made significant progress in fiscal 2024. HF Foods Group Inc. (NASDAQ:HFFG) has been working to capitalize on the growth opportunities in the Asian food services market. During the fiscal fourth quarter of 2024, the company generated $305.3 million in revenue up 8.7% year-over-year. This growth was driven by the volume growth with new wholesale accounts and improved pricing for some categories. In addition, the management of HF Foods Group Inc. (NASDAQ:HFFG) has been able to reduce its distribution, selling, and administrative expenses as a percentage of net revenue, which helped take revenue higher.
Moreover, the company is expanding into high-growth channels including the specialty grocery and e-commerce to reduce its reliance on the restaurant segment which has been facing pressure due to inflation. It is one of the best-rising penny stocks to buy according to analysts.
5. Sportsman’s Warehouse Holdings, Inc. (NASDAQ:SPWH)
Price: $1.49
1-Month Performance: 41.90%
Analyst Upside Potential: 101.34%
Number of Hedge Fund Holders: 22
Sportsman’s Warehouse Holdings, Inc. (NASDAQ:SPWH) is a retailer of outdoor sports goods and caters to sports including hunting, shooting, reloading, camping, fishing, and other outdoor recreational activities. The company operates around 145 stores across 29 states in the US. On April 2, Craig-Hallum upgraded the stock from Hold to a Buy rating on the stock with a price target of $3. The firm based its upgrade on positive operational improvements including increase in comparable sales for fishing and camping during the fiscal fourth quarter of 2024. The firm believes that despite the pressures from inflation and consumer confidence the stock is undervalued.
Sportsman’s Warehouse Holdings, Inc. (NASDAQ:SPWH) has been stabilizing its core business. During the fiscal fourth quarter of 2024, same-store sales of the company declined by only 0.5% on a 13-week basis, compared to the 12.8% decline last year. Moreover, the adjusted EBITDA increased from $5.3 million last year to $14.6 million in Q4 2024. Management noted that this reflects better margins, especially in the footwear category. Despite the market challenges coming from the inflationary market and recession fear, management expects to return to positive same-store sales growth during the current year for the first time since 2020. Sportsman’s Warehouse Holdings, Inc. (NASDAQ:SPWH) is one of the best-rising penny stocks to buy according to analysts.
4. SurgePays, Inc. (NASDAQ:SURG)
Price: $2.34
1-Month Performance: 93.39%
Analyst Upside Potential: 113.68%
Number of Hedge Fund Holders: 4
SurgePays, Inc. (NASDAQ:SURG) is a fintech and communications company that focuses on providing financial and connectivity services to underbanked communities in the United States. It operates through two main segments including the Mobile Virtual Network Operator Telecommunications segment and Comprehensive Platform Services.
The company faced losses in fiscal 2024, the revenue fell to $60.9 million, reflecting a 56% decrease year-over-year. This was mainly due to the shutdown of the federal Affordable Connectivity Program (ACP) funding. However, despite the losses SurgePays, Inc.’s (NASDAQ:SURG) Comprehensive Platform Services segment performed positively as revenue grew from $11.3 million in 2023 to $17.4 million in 2024. Management has been utilizing its cash reserves to transition ACP subscribers to new business models including its LinkUp Mobile and Lifeline, and is also investing in upgrading its retail platform.
In addition to this, the company was also able to complete its strategic integration with AT&T which led to the launch of LinkUp Mobile. This new business model is expected to contribute to growth for SurgePays, Inc. (NASDAQ:SURG) and analysts expect more than 113% upside for the stock, making it one of the best-rising penny stocks to buy according to analysts.
3. TuHURA Biosciences, Inc. (NASDAQ:HURA)
Price: $4.11
1-Month Performance: 69.63%
Analyst Upside Potential: 167.97%
Number of Hedge Fund Holders: 3
TuHURA Biosciences, Inc. (NASDAQ:HURA) is a registration-stage biotechnology company that specializes in immuno-oncology. Its lead product IFx-2.0 is a personalized cancer vaccine. The company is to initiate a pivotal, randomized, placebo-controlled Phase III trial of IFx-2.0 as an adjunctive therapy to Keytruda.
On March 3rd, H.C. Wainwright initiated coverage on the stock with a Buy rating and a $13 price target. The firm noted that IFx-2.0 has demonstrated an encouraging overall response rate in phase 1b. The year 2024 was a pivotal year for TuHURA Biosciences, Inc. (NASDAQ:HURA) as it became listed on the NASDAQ exchange. The company also raised capital to meet the FDA’s manufacturing requirement to initiate phase 3. Management noted that they are advancing into the last stage of the clinical program in 2025 and anticipate completing the enrollment for phase 3 by next year. It is one of the best penny stocks to buy according to analysts.
2. Microbot Medical Inc. (NASDAQ:MBOT)
Price: $2.55
1-Month Performance: 53.61%
Analyst Upside Potential: 252.94%
Number of Hedge Fund Holders: 1
Microbot Medical Inc. (NASDAQ:MBOT) is a preclinical medical device company that specializes in the design and development of robotic systems for minimally invasive endoluminal surgery. Its key products include Liberty Endovascular Robotic Surgical System, which is a disposable single-use robotic system for endovascular procedures, and NovaCross, which is a platform for intraluminal revascularization devices. The company is currently in the pre-commercial stage advancing its technology for regulatory approvals and market launches.
On April 9, Microbot Medical Inc. (NASDAQ:MBOT) presented clinical data for Liberty Endovascular Robotic Surgical System, which showed 100% success in robotic navigation and a 92% reduction in radiation exposure with no adverse events. The result shows that the system is feasible and safe for medical procedures. It is one of the best-rising penny stocks to buy according to analysts as analysts expect more than 252% upside from the current levels.
1. Regulus Therapeutics Inc. (NASDAQ:RGLS)
Price: $1.95
1-Month Performance: 42.34%
Analyst Upside Potential: 284.62%
Number of Hedge Fund Holders: 13
Regulus Therapeutics Inc. (NASDAQ:RGLS) is another clinical-stage pharmaceutical company that engages in the development of medicines that target microRNAs to treat various unmet medical conditions. Its key focus area includes Orphan Kidney Disease with Farabursen being its main drug candidate.
On March 31, Leerink Partners analyst Joseph Schwartz reiterated a Buy rating on Regulus Therapeutics Inc. (NASDAQ:RGLS). The analyst noted that the company’s lead drug candidate for treating ADPKD showed positive results in the fourth cohort of the phase 1b study. The results indicate that the drug is effective in curbing the growth of height-adjusted total kidney volume. Moreover, Schwartz also likes the company’s engagement with the FDA which topped with the positive results points towards speedy approvals. Considering these positive factors, analysts anticipate more than 284% upside for the stock, making it the best-rising penny stock to buy according to analysts.
While we acknowledge the potential of RGLS to grow, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. There is an AI stock that went up since the beginning of 2025, while popular AI stocks lost around 25%. If you are looking for an AI stock that is more promising than RGLS but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
READ NEXT: 20 Best AI Stocks To Buy Now and 30 Best Stocks to Buy Now According to Billionaires.
Disclosure. None. Insider Monkey focuses on uncovering the best investment ideas of hedge funds and investors. Please subscribe to our daily free newsletter to get the latest investment ideas from hedge funds’ investor letters by entering your email address below.
